Psychosis Market Outlook (2026–2030) Driven by Growth Factors

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Psychosis Market Progress Between 2026 And 2030?

The psychosis market has experienced robust expansion in recent times. Projected figures indicate its value will rise from $10.46 billion in 2025 to $11.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.8%. Historically, this expansion can be linked to several factors, including the increasing diagnosis of schizophrenia and related disorders, the expansion of hospital-based psychiatric care, the wider use of antipsychotic medications, growing mental health awareness, and the availability of specialized mental health clinics.

The psychosis market is projected to experience robust expansion over the coming years. Its valuation is set to reach $13.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. This anticipated growth stems from several factors, including heightened investment in developing new antipsychotic drugs, a greater emphasis on managing psychosis in its early stages, the proliferation of community-based mental health support, wider uptake of digital therapeutic solutions, and an escalating need for comprehensive long-term disease management. Key developments during this timeframe are expected to involve a greater reliance on long-acting injectable antipsychotics, increased implementation of early intervention initiatives, an evolving focus towards integrated care frameworks, the widespread availability of digital monitoring instruments for psychosis, and a stronger commitment to individualized treatment strategies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

Which Strong Drivers Are Impacting The Psychosis Market Growth?

The anticipated expansion of the psychosis market is primarily fueled by a surge in mental health conditions. These conditions are disorders that affect an individual’s mood, thought processes, behavior, and overall mental well-being. This rise in mental health issues is attributed to factors such as elevated stress levels, evolving lifestyles, social isolation, economic pressures, and genetic predispositions. Psychosis treatment plays a crucial role in assisting patients with these challenges through timely diagnosis, medical interventions, and specialized therapies, consequently increasing the adoption of antipsychotic medications and various therapy options. For instance, data from the American Psychiatric Association, a professional organization for psychiatrists in the US, indicated in May 2024 that 43% of adults reported elevated anxiety levels compared to the previous year, an increase from 37% in 2023 and 32% in 2022. Consequently, the growing prevalence of mental health conditions is a significant catalyst for the growth of the psychosis market.

What Are The Different Segment Types In The Psychosis Market Segment Breakdown?

The psychosis market covered in this report is segmented –

1) By Product: Tablet, Capsule, Injection

2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types

3) By Distribution Channel: Online, Offline

4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users

Subsegments:

1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets

2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules

3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics

Which Trends Are Contributing To Changes In The Psychosis Market?

Major organizations operating in the psychosis market are increasingly concentrating on implementing advanced patient-voice and data-collection initiatives. These efforts are geared towards refining service design, influencing policy decisions, and promoting recovery-oriented care. Patient-voice initiatives allow individuals with firsthand experience and their families to communicate their needs, challenges, and outcomes directly through structured surveys and research, thereby supporting evidence-based advocacy and more effective system reforms. As an illustration, in November 2025, Shine, an Ireland-based national mental health organization, in partnership with Mental Health Reform, an Ireland coalition on mental health, and the HSE National Clinical Programme for Early Intervention in Psychosis (EIP), launched the 2025 National Survey of the Experiences of People Living with Psychosis. This specific initiative gathers direct perspectives from individuals with psychosis and their families to identify their real-world experiences regarding access to care, highlight systemic gaps and stigma, and provide direction for improvements in national policy, investment in specialist early intervention services, and the expansion of community-based and crisis support options.

Who Are The Well-Known Companies In The Psychosis Market?

Major companies operating in the psychosis market are Pfizer Inc., Johnson And Johnson, AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Dr Reddys Laboratories Ltd., Lundbeck AS, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals SpA, BioXcel Therapeutics, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Zydus Lifesciences Ltd.

Get The Full Psychosis Market Report:

https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

Which Region Represents The Largest Share Of The Psychosis Market?

North America was the largest region in the psychosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Psychosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

Browse Through More Reports Similar to the Global Psychosis Market 2026, By The Business Research Company

Lawn Mower Market Report 2026

https://www.thebusinessresearchcompany.com/report/lawn-mower-global-market-report

Lawn Mowers Market Report

https://www.thebusinessresearchcompany.com/report/lawn-mowers-global-market-report

Robotic Lawn Mower Market Report

https://www.thebusinessresearchcompany.com/report/robotic-lawn-mower-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795